Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR
Cohen Matthew Gregory received 11,882 Arrowhead Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Jun 15, 2026 · Filed Jun 17, 2026
On Jun 15, 2026, Cohen Matthew Gregory (Director) received 11,882 Arrowhead Pharmaceuticals, Inc. shares as an award, leaving 11,882 shares. Filed Jun 17, 2026 (Form 4).
- Awarded
- 11,882 shares
- Holding after
- 11,882 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | Award | 11,882 | 11,882 | Direct |
Source
Related
- Arrowhead Pharmaceuticals, Inc.
- Cohen Matthew Gregory
- Arrowhead Pharmaceuticals, Inc. shareholders
- Form 4 · Olukotun Adeoye Y · Aug 20, 2026
- Form 4 · Perry Michael S · Aug 20, 2026
- Schedule 13G/A · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026